chr3-165786245-A-T
Position:
Variant summary
Our verdict is Likely pathogenic. Variant got 7 ACMG points: 7P and 0B. PVS1_StrongPM2PP5
The NM_000055.4(BCHE):c.1584T>A(p.Tyr528*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000013 in 1,612,144 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.000020 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000012 ( 0 hom. )
Consequence
BCHE
NM_000055.4 stop_gained
NM_000055.4 stop_gained
Scores
2
2
3
Clinical Significance
Conservation
PhyloP100: 0.643
Genes affected
BCHE (HGNC:983): (butyrylcholinesterase) This gene encodes a cholinesterase enzyme and member of the type-B carboxylesterase/lipase family of proteins. The encoded enzyme exhibits broad substrate specificity and is involved in the detoxification of poisons including organophosphate nerve agents and pesticides, and the metabolism of drugs including cocaine, heroin and aspirin. Humans homozygous for certain mutations in this gene exhibit prolonged apnea after administration of the muscle relaxant succinylcholine. [provided by RefSeq, Jul 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_pathogenic. Variant got 7 ACMG points.
PVS1
Loss of function variant, product does not undergo nonsense mediated mRNA decay. Variant is located in the 3'-most 50 bp of the penultimate exon, not predicted to undergo nonsense mediated mRNA decay. Fraction of 0.124 CDS is truncated, and there are 1 pathogenic variants in the truncated region.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 3-165786245-A-T is Pathogenic according to our data. Variant chr3-165786245-A-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 555346.We mark this variant Likely_pathogenic, oryginal submissions are: {Uncertain_significance=1, Pathogenic=1, Likely_pathogenic=2}.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
BCHE | NM_000055.4 | c.1584T>A | p.Tyr528* | stop_gained | 3/4 | ENST00000264381.8 | NP_000046.1 | |
BCHE | NR_137635.2 | n.177T>A | non_coding_transcript_exon_variant | 2/3 | ||||
BCHE | NR_137636.2 | n.1702T>A | non_coding_transcript_exon_variant | 3/5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
BCHE | ENST00000264381.8 | c.1584T>A | p.Tyr528* | stop_gained | 3/4 | 1 | NM_000055.4 | ENSP00000264381.3 |
Frequencies
GnomAD3 genomes AF: 0.0000198 AC: 3AN: 151848Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
3
AN:
151848
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000639 AC: 16AN: 250512Hom.: 0 AF XY: 0.0000517 AC XY: 7AN XY: 135424
GnomAD3 exomes
AF:
AC:
16
AN:
250512
Hom.:
AF XY:
AC XY:
7
AN XY:
135424
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000123 AC: 18AN: 1460296Hom.: 0 Cov.: 31 AF XY: 0.0000138 AC XY: 10AN XY: 726474
GnomAD4 exome
AF:
AC:
18
AN:
1460296
Hom.:
Cov.:
31
AF XY:
AC XY:
10
AN XY:
726474
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000198 AC: 3AN: 151848Hom.: 0 Cov.: 32 AF XY: 0.0000270 AC XY: 2AN XY: 74182
GnomAD4 genome
AF:
AC:
3
AN:
151848
Hom.:
Cov.:
32
AF XY:
AC XY:
2
AN XY:
74182
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ExAC
AF:
AC:
2
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:3Uncertain:1
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
Deficiency of butyrylcholinesterase Pathogenic:3Uncertain:1
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Feb 28, 2024 | Variant summary: BCHE c.1584T>A (p.Tyr528X) results in a premature termination codon, predicted to cause absence of the protein due to nonsense mediated decay, which is a commonly known mechanism for disease. The variant allele was found at a frequency of 6.4e-05 in 250512 control chromosomes (gnomAD). This frequency is not significantly higher than estimated for a pathogenic variant in BCHE causing Deficiency Of Butyrylcholine Esterase (6.4e-05 vs 0.016), allowing no conclusion about variant significance. c.1584T>A has been reported in the literature in an individual affected with Deficiency Of Butyrylcholine Esterase who was compound heterozygous with another pathogenic variant (Primo-Parmo_1996). The following publication has been ascertained in the context of this evaluation (PMID: 8554068). ClinVar contains an entry for this variant (Variation ID: 555346). Based on the evidence outlined above, the variant was classified as pathogenic. - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Counsyl | Dec 01, 2017 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 28, 2017 | The BCHE c.1584T>A (p.Tyr528Ter) stop-gained variant, also referred to as BCHE*500STOP, has been reported in a compound heterozygous state with a frameshift variant in one individual who was described as having sensitivity to succinylcholine and showed no BCHE protein activity in a plasma sample (Primo-Parmo et al. 1996). Control data are unavailable for this variant, which is reported at a frequency of 0.00018 in the Latino population of the Exome Aggregation Consortium, but this is based on two alleles so the variant is presumed to be rare. Due to the potential impact of stop-gained variants and the evidence from the literature, the p.Tyr528Ter variant is classified as a variant of unknown significance but suspicious for pathogenicity for butyrylcholinesterase deficiency. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population. - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Oct 15, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
Eigen
Uncertain
Eigen_PC
Benign
FATHMM_MKL
Benign
D
Vest4
GERP RS
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at